Form D · Biotechnology
CUREMARK LLC
Rye Brook, NY · CIK 0001439430
Offering snapshot reported Mar 27, 2023 · SEC filing
- Reported sold
- $1.3M Offering amount: $15M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 30, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 27, 2023 | Initial | $1,295,000 | No comparison | 5 | SEC filing |
| Apr 14, 2021 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Sep 11, 2019 | Initial | $5,405,000 | No comparison | 1 | SEC filing |
| Apr 26, 2018 | Initial | $1,675,000 | No comparison | 1 | SEC filing |
| Jan 29, 2018 | Initial | $3,245,000 | No comparison | 1 | SEC filing |
| Mar 20, 2017 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
| Jul 13, 2015 | Initial | $20,250,000 | No comparison | 2 | SEC filing |
| Jan 14, 2015 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jan 14, 2014 | Initial | $18,752,466 | No comparison | 66 | SEC filing |
| Feb 5, 2013 | Amendment | $6,042,000 | $3,772,000vs Mar 14, 2012 | 37 | SEC filing |
| Mar 14, 2012 | Initial | $2,270,000 | No comparison | 10 | SEC filing |
| Jul 29, 2010 | Initial | $5,220,000 | No comparison | 3 | SEC filing |
| Feb 22, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 19, 2009 | Amendment | $6,324,857 | No comparison | 110 | SEC filing |
| Jul 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476947
Source: Form D, filed Mar 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Afia Asamoah | Director |
| Kimball Duncan | Director |
| Kimbell Duncan | Director |
| Joan Fallon | Director, Executive |
| Jennifer Frist | Director |
| Matthew Heil | Executive |
| Eric Herman | Director |
| Eric Hermann | Director |
| Klaus Kleinfeld | Director |
| Jzaneen Lalani | Executive |
| Leigh Morgan | Director |
| Justin Stebbing | Director |
| Elisa Zinberg | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
800 Westchester Avenue
Rye Brook, NY, 10573
Rye Brook, NY, 10573